You just read:

Argos Therapeutics' Arcelis™ HIV Immunotherapy Shows Feasibility to Generate Fully Functional Dendritic Cells From Viremic Patients

News provided by

Argos Therapeutics, Inc.

Dec 09, 2010, 08:00 ET